Neurodegeneration and inflammation in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Phani, Sudarshan ^a   Loike, John D ^a   Przedborskia, Serge ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adaptive immune system; Astrocyte; Inflammation; Innate immune system; Microglia; MPTP; Parkinson's disease; T lymphocytes

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYTOKINE; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ARTICLE; ASTROCYTE; CELL ACTIVATION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; LEWY BODY; LYMPHOCYTIC INFILTRATION; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SUBSTANTIA NIGRA PARS COMPACTA; T LYMPHOCYTE; ADAPTIVE IMMUNITY; BLOOD BRAIN BARRIER; CELL ACTIVITY; CELL FUNCTION; CELL INFILTRATION; CELL STRUCTURE; INNATE IMMUNITY; MPTP-INDUCED PARKINSONISM; NERVOUS SYSTEM INFLAMMATION;

EID: 84858650685     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70064-5     Document Type: Article

References (19)

1. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909.
2. Cookson MR. The biochemistry of Parkinson's disease. Ann Rev Biochem 2005; 74:29-52.
3. Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW. Astrocytes and Parkinson's disease. Prog Brain Res 1992;94:429-36.
4. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-91.
5. Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003;60:1059-64.
6. Khandelwal PJ, Herman AM, Moussa CE-H. Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 2011.
7. Brochard V, Combadière B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 2009;119:182-92.
8. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006;12:829-34.
9. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 2003;9:453-7.
10. Napoli I, Neumann H. Microglial clearance function in health and disease. Neuroscience 2009;158:1030-8.
11. Batchelor PE, Porritt MJ, Martinello P, Parish CL, Liberatore GT, Donnan GA, et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci 2002;21:436-53.
12. Kirschner PB, Jenkins BG, Schulz JB, Finkelstein SP, Matthews RT, Rosen BR, et al. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Res 1996;713:178-85.
13. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995;373:335-9.
14. Smith MP, Cass WA. GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. Neurosci Lett 2007;412:259-63.
15. Przedborski S. Neuroinflammation and Parkinson's disease. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology 2007;83:535-51.
16. Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol J-C, Lu L, et al. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A 2011;108:6632-7.
17. Long-Smith CM, Sullivan AM, Nolan YM. The influence of microglia on the pathogenesis of Parkinson's disease. Prog Neurobiol 2009;89:277-87.
18. Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord 2011;26:6-17.
19. Whitton PS. Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease. Curr Opin Invest Drugs 2010;11:788-94.